Merck braces for Vioxx trial No. 3
Merck & Co. Inc. is preparing for its third Vioxx trial, this one from a Florida woman whose husband died of a heart attack.
Jury selection was to begin Tuesday in Houston, the Chronicle reported Monday.
New Jersey-based Merck lost the first Vioxx trial and was hit with a $253 million verdict. It won the second trial.
The pharmaceutical company, which Monday announced massive layoffs and numerous factory closures, pulled its blockbuster painkiller off the market in September 2004 after researchers said it doubled the risk of heart attacks and strokes in patients who took it for 18 months or longer.
Merck is believed to face an estimated legal liability of some $20 billion in about 6,500 Vioxx cases nationwide. e latest breaking news concerning VIOXX
Jury selection was to begin Tuesday in Houston, the Chronicle reported Monday.
New Jersey-based Merck lost the first Vioxx trial and was hit with a $253 million verdict. It won the second trial.
The pharmaceutical company, which Monday announced massive layoffs and numerous factory closures, pulled its blockbuster painkiller off the market in September 2004 after researchers said it doubled the risk of heart attacks and strokes in patients who took it for 18 months or longer.
Merck is believed to face an estimated legal liability of some $20 billion in about 6,500 Vioxx cases nationwide. e latest breaking news concerning VIOXX
posted by Chris Placitella at 6:43 AM
0 Comments:
Post a Comment
<< Home